Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT06203041
Infants The purpose of this study is to measure breastmilk's vitamin D sulfate nutritional value in infant's saliva and digesta (gut).
Breastfeeding Mothers The purpose of this study is to measure Vitamin D sulfates in freshly expressed breastmilk samples before and after 28 days of Vitamin D supplementation in lactating mothers.
Looking for future studies?
Notify Me1 month–60 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Infants
Sign the consent form to confirm participation:
You will be asked to bring a soiled diaper from the morning of the study visit. You will meet with a study team member who will collect up to 6 swabs total:
Up to 3 cheek/mouth swabs to collect saliva Up to 3 stool/anus/diaper swabs
Lactating Mothers
Sign the consent form to confirm participation:
Visit 1 (Baseline) You will meet with a study team member complete some demographic information and gestational age of the baby and birthdate, next you will have a blood draw and express breast milk in a private location, the study team will collect up to 50 ml of freshly expressed breast milk for the research study, you will be asked to bring your personal breast pump and collection container to each research visit, or manually express milk, see options below. The study team member will schedule visit 2. The study will provide the vitamin D supplement that you will take daily for 28 days.
Visit 2 (post intervention) Approximately 28 days later you will meet with a study team member, have a blood draw and express breast milk in a private location, the study team will collect up to 50 ml of freshly expressed breast milk for the research study, you will be asked to bring your personal breast pump and collection container to each research visit, or manually express milk, see options below. The study team member will ask for the container the Vitamin D supplement was in.
You have 2 options:
Option 1:
Bring along your personal breast pump and collection container to each study visit.
The study team member will collect up to 50 ml of freshly expressed breast milk for the study.
Option 2:
You do not bring along your personal breast pump and containers to each study visit, instead you will be asked to:
Manually express your breast milk into a specimen collection cup at each study visit.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Lactating Mothers
Inclusion criteria
Exclusion criteria
Breastfeeding Infants
Inclusion criteria
Exclusion criteria
Orally administered, daily dose of 5000 IU (125 mcg) Vitamin D3 for 28 days.
Other names: cholecalciferol
Time frame: Baseline, Day 28
Samples will be assessed using a Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) assay on the Agilent 6490 tandem mass spectrometer instrument.
Time frame: Baseline
Samples will first be assessed for activity using a general sulfatase activity assay, followed by a Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) assay on the Agilent 6490 tandem mass spectrometer instrument.
Time frame: Baseline
Samples will first be assessed for activity using a general sulfatase activity assay, followed by a Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) assay on the Agilent 6490 tandem mass spectrometer instrument.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631312
Anemia, Anemia, Hypochromic
Atlanta, Georgia, United States
View Trial DetailsNCT06700122
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT06654063
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT07481240
Avitaminosis, Deficiency Diseases
Cork, Co. Cork, Ireland
View Trial Details